Rallybio shares successful early-stage results for rare disease drug; new trial set for late 2026

Rallybio Corporation RLYB on Tuesday shared results from its Phase 1 confirmatory pharmacokinetic/pharmacodynamic (PK/PD) clinical trial of RLYB116 for complement-mediated diseases, with its initial ...
Frontiers

Effects of Environmental Perturbations on Brain Functions, Diseases, and Disorders

The field of molecular neuroscience has increasingly recognized that, while the nervous system is characterized by impressive resilience and plasticity, it ...

A Look At China Medical System Holdings (SEHK:867) Valuation After New AI Drug Partnership And Trial Approval

Why these new drug moves matter for China Medical System Holdings China Medical System Holdings (SEHK:867) has been busy on two fronts, pairing with Insilico Medicine on AI-powered drug discovery ...
IEEE

MindWellQA: A Semantically Enriched Evidence-Based QA System for Psychological Disorders

The increasing prevalence of psychological disorders highlights the urgent need for early diagnosis and intervention. While advanced humanoid Large Language Models (LLMs) offer potential for ...
Nature

CAR-T therapy provides relief for children with autoimmune diseases

Symptoms and organ damage abated in young children and teenagers whose conditions had resisted other treatments.
IEEE

Cardiac Diagnosis System For Heart Diseases Classification Based on Deep Learning and Optimization Strategies Using ECG Signals

Abstract: Heart disease is among the leading causes of death worldwide. Significant factors include other cardiovascular disorders, such as aortic disease, coronary artery disease, and arrhythmia. The ...